{"id":71470,"date":"2026-05-20T11:55:00","date_gmt":"2026-05-20T11:55:00","guid":{"rendered":"https:\/\/medsbase.com\/?post_type=product&#038;p=71470"},"modified":"2026-10-15T10:33:56","modified_gmt":"2026-10-15T10:33:56","slug":"l-glutathione-reduced-gsh","status":"publish","type":"product","link":"https:\/\/medsbase.com\/es\/product\/l-glutathione-reduced-gsh\/","title":{"rendered":"L-Glutathione (Reduced \/ GSH) Injectable \u2014 Pharmaceutical Grade"},"content":{"rendered":"<p><!-- medsbase-tldr-answer --><\/p>\n<div style=\"background: #fff8e1; border-left: 4px solid #f5a623; padding: 18px 22px; margin: 18px 0; border-radius: 4px;\">\n<h3 style=\"margin: 0 0 8px 0; font-size: 16px; color: #1a4a6b;\">Respuesta r\u00e1pida \u2014 \u00bfQu\u00e9 es el glutati\u00f3n (GSH)?<\/h3>\n<p style=\"margin: 0;\"><strong>L-Glutati\u00f3n (reducido; GSH)<\/strong> es el trip\u00e9ptido \u03b3-glutamil-cisteinil-glicina (\u03b3-Glu-Cys-Gly), CAS 70-18-8, f\u00f3rmula molecular C<sub>10<\/sub>H<sub>17<\/sub>N<sub>3<\/sub>O<sub>6<\/sub>S, MW 307.32 g\/mol. GSH is the most abundant non-protein cellular thiol (millimolar intracellular concentrations) and the canonical reference compound for cellular antioxidant defence studies. The unique <strong>\u03b3<\/strong> between glutamate&#8217;s \u03b3-carboxyl and cysteine&#8217;s amino group (rather than the standard \u03b1-peptide bond) makes GSH resistant to common peptidases \u2014 only \u03b3-glutamyltransferase (\u03b3-GT) can cleave it. Cells use GSH as the primary electron donor for glutathione peroxidase-mediated hydrogen-peroxide reduction, as the conjugating co-substrate for glutathione-S-transferase-mediated xenobiotic detoxification, and as the redox-status buffer that controls protein thiol-disulfide equilibrium. Supplied here as lyophilized USP-grade powder for clinical studies use only.<\/p>\n<\/div>\n<div class=\"medsbase-trust-strip\" style=\"background: #f4f8fb; border: 1px solid #d8e3eb; padding: 12px 16px; margin: 16px 0; border-radius: 4px; font-size: 14px;\"><strong>Qu\u00e9 obtienes con MedsBase:<\/strong> Pharmaceutical-grade lyophilized peptides &middot; HPLC &ge;99% purity (COA on request) &middot; Discreet protective packaging &middot; Worldwide peptide courier &middot; 1,400+ verified <a href=\"https:\/\/medsbase.com\/es\/reviews\/\">opiniones de clientes<\/a><\/div>\n<p class=\"medsbase-reship-line\" style=\"font-size: 14px; color: #444; margin: 8px 0 18px;\">\ud83d\udce6 Cada pedido est\u00e1 cubierto por nuestra <a href=\"https:\/\/medsbase.com\/es\/medsbase-re-shipment-assurance-policy\/\"><strong>Reshipment Assurance Policy<\/strong><\/a> \u2014 si tu paquete no llega en 20 d\u00edas laborables, lo reenviamos.<\/p>\n<table class=\"medsbase-spec-table\" style=\"width: 100%; border-collapse: collapse; margin: 18px 0; font-size: 14px;\">\n<thead>\n<tr style=\"background: #2c7cb0; color: #fff;\">\n<th style=\"padding: 8px 12px; text-align: left; width: 30%;\">Especificaci\u00f3n<\/th>\n<th style=\"padding: 8px 12px; text-align: left;\">Detalle<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Clase de compuesto<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">\u03b3-Glutamyl tripeptide; primary cellular non-protein thiol antioxidant; small-molecule peptide (\u03b3-linked, peptidase-resistant)<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Nombre qu\u00edmico<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">L-Glutati\u00f3n, reducido (\u03b3-L-glutamil-L-cisteinil-glicina; sin\u00f3nimos: GSH, \u00e1cido libre de glutati\u00f3n, glutati\u00f3n reducido)<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>N\u00famero CAS<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">70-18-8 (forma reducida de GSH); relacionado: 27025-41-8 (forma dim\u00e9rica oxidada GSSG, no suministrada aqu\u00ed)<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>F\u00f3rmula molecular<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">C<sub>10<\/sub>H<sub>17<\/sub>N<sub>3<\/sub>O<sub>6<\/sub>S<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Peso molecular<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">307.32 g\/mol (\u00e1cido libre)<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Secuencia<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">\u03b3-L-Glutamil-L-cisteinil-glicina (\u03b3-Glu-Cys-Gly). N\u00f3tese el <strong>\u03b3<\/strong> enlace entre la cadena lateral \u03b3-COOH del glutamato y el grupo \u03b1-amino de la ciste\u00edna, en lugar del enlace pept\u00eddico \u03b1 est\u00e1ndar. Esta uni\u00f3n no est\u00e1ndar es lo que hace al GSH resistente a las \u03b1-peptidasas comunes \u2014 solo la \u03b3-glutamiltransferasa (\u03b3-GT) lo escinde, que es el paso limitante en la degradaci\u00f3n y reciclaje extracelular del GSH.<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Mecanismo<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\"><strong>Tres funciones celulares primarias<\/strong>. (1) <em>Donante de electrones para la glutati\u00f3n peroxidasa<\/em> (familia GPx) \u2014 2 GSH + H\u2082O\u2082 \u2192 GSSG + 2 H\u2082O, la reacci\u00f3n can\u00f3nica de reducci\u00f3n celular de per\u00f3xido de hidr\u00f3geno; el GSSG luego se reduce nuevamente a 2 GSH por la glutati\u00f3n reductasa dependiente de NADPH. (2)<sub>2<\/sub>O<sub>2<\/sub> Co-sustrato para la glutati\u00f3n-S-transferasa<sub>2<\/sub>(familia GST) \u2014 conjuga el GSH a sustratos xenobi\u00f3ticos y end\u00f3genos electr\u00f3filos, generando conjugados de \u00e1cido mercapt\u00farico excretables (la v\u00eda central de desintoxicaci\u00f3n hep\u00e1tica). (3) <em>Buffer del estado redox<\/em> \u2014 la proporci\u00f3n GSH:GSSG (t\u00edpicamente ~100:1 en c\u00e9lulas sanas) controla el equilibrio tiol-disulfuro de prote\u00ednas mediante intercambio mediado por tiorredoxina y glutaredoxina, regulando miles de actividades proteicas sensibles al redox. <em>Polvo cristalino liofilizado de blanco a blanquecino; viales de investigaci\u00f3n de un solo uso.<\/em> Altamente higrosc\u00f3pico.<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Forma<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">Lyophilized white-to-off-white crystalline powder; single-use vials. <strong>Highly hygroscopic<\/strong> \u2014 vuelva a sellar los viales inmediatamente despu\u00e9s de cada extracci\u00f3n para evitar la absorci\u00f3n de humedad.<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Pureza<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">\u226599% (verificado por HPLC, COA disponible bajo petici\u00f3n); la titulaci\u00f3n confirma \u226598% en forma reducida de GSH (\u22642% de contenido oxidado como GSSG). Referencia de grado USP.<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Solubilidad<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">Agua 20 mg\/mL; PBS (pH 7,2) 10 mg\/mL \u2014 f\u00e1cilmente soluble en las concentraciones suministradas en los viales. El grupo tiol (-SH) hace que el GSH sea sensible a la oxidaci\u00f3n por el aire \u2014 prepare soluciones de trabajo frescas a partir del vial liofilizado y util\u00edcelas en un plazo de 24 horas siempre que sea posible. El DMSO es un co-solvente adecuado para la preparaci\u00f3n de reservas para cultivos celulares (hasta 100 mg\/mL) y proporciona protecci\u00f3n adicional contra la oxidaci\u00f3n por el aire.<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Almacenamiento<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">Liofilizado: 2\u20138 \u00b0C en el envase original sellado para reservas de trabajo a corto plazo; \u221220 \u00b0C para el almacenamiento a largo plazo de viales sin abrir (estable \u226536 meses a \u221220 \u00b0C; \u226518 meses a 2\u20138 \u00b0C). Soluciones acuosas reconstituidas: 2\u20138 \u00b0C, usar en ~7 d\u00edas (la oxidaci\u00f3n por el aire a GSSG es el factor limitante). Proteger de la luz. <strong>Evite la congelaci\u00f3n-descongelaci\u00f3n repetida de las soluciones reconstituidas<\/strong> \u2014 los ciclos acumulativos aceleran la oxidaci\u00f3n GSH \u2192 GSSG.<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><!-- \/medsbase-tldr-answer --><\/p>\n<h2>\u00bfQu\u00e9 es la L-Glutati\u00f3n (Reducido\/GSH)?<\/h2>\n<p><strong>L-Glutati\u00f3n (forma reducida, GSH)<\/strong> es el tiol celular no proteico m\u00e1s abundante en la biolog\u00eda eucariota \u2014 presente en concentraciones intracelulares milimolares (1\u201310 mM en la mayor\u00eda de los tipos celulares; hasta 10 mM en hepatocitos) y sirviendo como el principal amortiguador molecular del estado redox celular. Estructuralmente es un trip\u00e9ptido de glutamato, ciste\u00edna y glicina (\u03b3-Glu-Cys-Gly), CAS 70-18-8, f\u00f3rmula molecular C<sub>10<\/sub>H<sub>17<\/sub>N<sub>3<\/sub>O<sub>6<\/sub>S, molecular weight 307.32 g\/mol. The defining structural feature of glutathione is its <strong>\u03b3<\/strong>. Los p\u00e9ptidos est\u00e1ndar est\u00e1n unidos mediante enlaces pept\u00eddicos \u03b1 entre el \u03b1-carboxilo de un amino\u00e1cido y el \u03b1-amino del siguiente. En el glutati\u00f3n, el enlace entre el glutamato y la ciste\u00edna es inusual: se forma entre el <em>\u03b3-carboxilo<\/em> of glutamate&#8217;s side chain and the \u03b1-amino of cysteine. This non-standard linkage is the molecular basis for glutathione&#8217;s resistance to common cellular peptidases \u2014 only \u03b3-glutamyltransferase (\u03b3-GT, GGT, EC 2.3.2.2) recognises and cleaves the \u03b3-bond. As a result, glutathione is uniquely stable in the cellular cytosol where it would otherwise be rapidly degraded by \u03b1-peptidase activity, and \u03b3-GT-mediated extracellular degradation is the rate-limiting step of glutathione recycling. Glutathione is synthesised in two ATP-dependent steps by the cytosolic enzymes <strong>glutamato-ciste\u00edna ligasa (GCL)<\/strong> \u2014 que forma el enlace \u03b3-glutamil-ciste\u00edna \u2014 y <strong>glutati\u00f3n sintetasa (GSS)<\/strong> \u2014 which adds the C-terminal glycine. GCL is the rate-limiting enzyme and is feedback-inhibited by glutathione itself, providing autoregulation of cellular glutathione levels. Cysteine availability is the other major rate-limiting input \u2014 which is why N-acetylcysteine (NAC), a cysteine prodrug, is the canonical clinical intervention for boosting cellular glutathione synthesis in oxidative-stress and detoxification contexts (the basis of NAC&#8217;s approval for paracetamol overdose and other clinical indications). Glutathione exists in cells in two interconverting forms: the <strong>forma reducida (GSH)<\/strong> con un grupo tiol libre (-SH), y la <strong>forma oxidada (GSSG)<\/strong> donde dos mol\u00e9culas de GSH est\u00e1n unidas por un puente disulfuro. La proporci\u00f3n GSH:GSSG (t\u00edpicamente ~100:1 en c\u00e9lulas sanas, descendiendo a 10:1 o menos bajo estr\u00e9s oxidativo) es el biomarcador redox celular can\u00f3nico. El GSSG se reduce de nuevo a 2 GSH mediante <strong>glutathione reductase (GR, GSR)<\/strong>, an NADPH-dependent flavoenzyme \u2014 connecting the GSH redox system to NADPH availability and ultimately to the pentose phosphate pathway. This is why pentose-phosphate-pathway disruption (G6PD deficiency, glucose-6-phosphate availability) impairs GSH-system function and triggers oxidative cell damage. The pharmaceutical-grade material supplied here is the reduced GSH form, supplied as lyophilized powder for reconstitution and protocol use alongside the peptide catalogue. <\/p>\n<h2>Mecanismo de acci\u00f3n \u2014 Tres funciones celulares primarias<\/h2>\n<p>El mecanismo biol\u00f3gico del GSH es la suma de tres funciones celulares primarias, todas bien caracterizadas en la bioqu\u00edmica publicada:<\/p>\n<ul>\n<li><strong>Sustrato de la glutati\u00f3n peroxidasa (GPx) \u2014 reducci\u00f3n del per\u00f3xido de hidr\u00f3geno y de los per\u00f3xidos lip\u00eddicos<\/strong> \u2014 La funci\u00f3n m\u00e1s citada del GSH. La familia de GPx (GPx1\u20138, siendo la GPx1 dependiente de selenio la m\u00e1s abundante) cataliza la reacci\u00f3n <em>2 GSH + ROOH \u2192 GSSG + ROH + H<sub>2<\/sub>O<\/em>, reduciendo el per\u00f3xido de hidr\u00f3geno y los hidroper\u00f3xidos lip\u00eddicos a agua y alcoholes, respectivamente. Esta es la principal defensa celular contra las especies reactivas de ox\u00edgeno generadas por la respiraci\u00f3n mitocondrial, la actividad de la NADPH-oxidasa y otros procesos oxidativos. La GPx4 es la isoforma espec\u00edfica que cataliza la reducci\u00f3n de hidroper\u00f3xidos lip\u00eddicos y es la diana molecular cuya p\u00e9rdida de funci\u00f3n desencadena <strong>ferroptosis<\/strong> \u2014 the iron-dependent regulated cell death pathway that has become a major focus of recent cancer-studies and neurodegenerative-disease studies.<\/li>\n<li><strong>Cosustrato de la glutati\u00f3n-S-transferasa (GST) \u2014 conjugaci\u00f3n de xenobi\u00f3ticos y endobi\u00f3ticos<\/strong> \u2014 La familia de GST (miembros citos\u00f3licos, microsomales y mitocondriales; ~20 isoformas humanas de GST) cataliza la conjugaci\u00f3n del GSH a sustratos electr\u00f3filos mediante el grupo tiol del GSH, generando aductos de conjugados GSH-S que posteriormente son procesados por la \u03b3-GT y las dipeptidasas hasta \u00e1cidos mercapt\u00faricos y excretados. Esta es la principal v\u00eda de desintoxicaci\u00f3n de fase II en el h\u00edgado y otros tejidos, procesando una amplia gama de xenobi\u00f3ticos (metabolitos de f\u00e1rmacos, qu\u00edmicos ambientales, productos del metabolismo de fase I del citocromo P450), electr\u00f3filos end\u00f3genos (4-hidroxinonenal, acrole\u00edna procedente de la peroxidaci\u00f3n lip\u00eddica) e intermediarios reactivos (NAPQI del paracetamol, base de la terapia con NAC en la sobredosis de paracetamol).<\/li>\n<li><strong>Buffer del estado redox \u2014 regulaci\u00f3n del equilibrio tiol-disulfuro en prote\u00ednas<\/strong> \u2014 The cellular GSH:GSSG ratio sets the thermodynamic equilibrium for protein-thiol redox state via thioredoxin- and glutaredoxin-mediated exchange. Thousands of cellular proteins have redox-sensitive cysteine residues whose thiol-disulfide state is regulated by this equilibrium \u2014 including key transcription factors (NF-\u03baB, AP-1, Nrf2, p53), signalling kinases (PTPs, PTEN), apoptosis machinery (caspases), and metabolic enzymes (glyceraldehyde-3-phosphate dehydrogenase, others). GSH-mediated redox buffering is therefore not just an antioxidant defence but a signalling regulatory mechanism \u2014 a fact that has emerged in published studies over the past two decades and is one of the most-cited rationales for the use of GSH in protocols beyond simple antioxidant supplementation.<\/li>\n<li><strong>Reserva de ciste\u00edna y tr\u00e1fico interorg\u00e1nico de amino\u00e1cidos<\/strong> \u2014 El GSH act\u00faa como reservorio tisular estable y transportable de ciste\u00edna, el amino\u00e1cido limitante para la s\u00edntesis de nuevas prote\u00ednas y para la s\u00edntesis adicional de GSH. La ciste\u00edna en forma libre es metab\u00f3licamente inestable (se autooxida a cistina, puede generar H<sub>2<\/sub>S, etc.), por lo que el organismo mantiene su reserva de ciste\u00edna principalmente como GSH y transporta la ciste\u00edna entre \u00f3rganos (especialmente h\u00edgado \u2192 ri\u00f1\u00f3n, h\u00edgado \u2192 otros tejidos) como GSH, que luego es procesado de nuevo a ciste\u00edna por la \u03b3-GT en el tejido diana.<\/li>\n<li><strong>Captaci\u00f3n directa de radicales<\/strong> \u2014 M\u00e1s all\u00e1 de sus roles enzim\u00e1ticos, el GSH reacciona directamente con el radical hidroxilo, el radical peroxilo y las especies reactivas de nitr\u00f3geno a trav\u00e9s del grupo tiol. Cuantitativamente, esto contribuye menos a la defensa antioxidante total que el mecanismo mediado por la GPx enzim\u00e1tica, pero es importante en compartimentos y condiciones donde los sistemas enzim\u00e1ticos est\u00e1n saturados o ausentes (GSH extracelular en el fluido del revestimiento pulmonar, GSH en la luz intestinal, etc.).<\/li>\n<\/ul>\n<p>The pharmacokinetic profile of injectable GSH is well-characterised: IV administration produces rapid systemic distribution with peak plasma concentrations within minutes, but plasma half-life is short (~10\u201315 minutes) due to rapid \u03b3-GT-mediated breakdown to cysteinylglycine and subsequent re-synthesis or further breakdown at target tissues. The brief plasma residence is one of the reasons why daily or twice-daily IV dosing protocols are common in published GSH studies. Cell-membrane permeability of intact GSH is low \u2014 cells primarily import the constituent amino acids and re-synthesise GSH intracellularly. This is why oral GSH is poorly bioavailable and why injectable preparations (or alternatively NAC as a cysteine prodrug) are required for effective tissue delivery in published studies. <\/p>\n<h2>Published Evidence<\/h2>\n<p>GSH is used in clinical contexts that investigate:<\/p>\n<ul>\n<li><strong>Defensa antioxidante celular \u2014 el compuesto de referencia can\u00f3nico<\/strong> \u2014 by far the most-cited cellular antioxidant in the published literature; standard reference compound for any new antioxidant intervention studies; the molecular gold standard for cellular redox-status analysis<\/li>\n<li><strong>Hydrogen peroxide and lipid peroxide reduction studies<\/strong> \u2014 direct GPx substrate; used in published studies on GPx isoform pharmacology, peroxide-handling pathway dissection, and the integration of GSH with thioredoxin and peroxiredoxin redox systems<\/li>\n<li><strong>Ferroptosis studies<\/strong> \u2014 GPx4-mediated lipid-hydroperoxide reduction is the gatekeeper of ferroptosis; GSH and its synthesis-pathway interventions (BSO, erastin, RSL3) are the canonical tools for ferroptosis induction \/ suppression studies in cancer, neurodegeneration, and ischaemia-reperfusion contexts<\/li>\n<li><strong>Phase II detoxification and xenobiotic-conjugation studies<\/strong> \u2014 GST substrate for the central liver-detoxification pathway; used in studies on drug-metabolite handling, environmental-chemical exposure, paracetamol-induced hepatotoxicity (NAPQI scavenging), and the broader pharmacology of mercapturic-acid conjugation<\/li>\n<li><strong>Protein-thiol redox signalling studies<\/strong> \u2014 the GSH:GSSG ratio controls thiol-disulfide equilibrium of thousands of cellular proteins; used in studies on redox-sensitive transcription factors (Nrf2, NF-\u03baB, AP-1), kinase regulation (PTPs, PTEN), and the broader cellular &#8220;redoxome&#8221;<\/li>\n<li><strong>Mitochondrial dysfunction and ageing studies<\/strong> \u2014 mitochondrial GSH levels decline with age and in many disease models; published studies uses exogenous GSH and GSH-pathway interventions to probe mitochondrial-redox contributions to ageing, neurodegeneration, and metabolic disease<\/li>\n<li><strong>Hepatology and liver-injury studies<\/strong> \u2014 GSH is most abundant in hepatocytes (5\u201310 mM concentration); used in published studies on alcoholic liver disease, NAFLD\/MASH, viral hepatitis models, and paracetamol-overdose \/ drug-induced liver injury<\/li>\n<li><strong>Hematology and erythrocyte studies<\/strong> \u2014 erythrocyte GSH is the major defence against oxidative haemolysis; used in studies on G6PD deficiency, sickle-cell disease, oxidative haemolysis pharmacology<\/li>\n<li><strong>Cancer redox and chemoprotection studies<\/strong> \u2014 many chemotherapeutic drugs generate ROS as part of their mechanism, and tumour cells often have elevated GSH levels; published studies uses GSH and GSH-pathway interventions to dissect chemotherapy redox biology<\/li>\n<\/ul>\n<p>For broader context on cellular cofactor and redox \/ antioxidant compounds in this catalogue, see <a href=\"https:\/\/medsbase.com\/es\/b12-cyanocobalamin\/\">B12 (Cianocobalamina)<\/a> (small-molecule companion cofactor \u2014 methylation cycle), <a href=\"https:\/\/medsbase.com\/es\/l-carnitine\/\">L-Carnitina<\/a> (lanzadera mitocondrial de \u00e1cidos grasos \u2014 peque\u00f1a mol\u00e9cula compa\u00f1era), <a href=\"https:\/\/medsbase.com\/es\/nad\/\">NAD\u207a<\/a> (suplementaci\u00f3n directa del pool de dinucle\u00f3tidos \u2014 transporte de electrones redox), <a href=\"https:\/\/medsbase.com\/es\/5-amino-1mq\/\">5-Amino-1MQ<\/a> (ahorro del eje NAD mediante inhibici\u00f3n de NNMT), y <a href=\"https:\/\/medsbase.com\/es\/ss-31-elamipretide\/\">SS-31 (Elamipretide)<\/a> (p\u00e9ptido antioxidante dirigido a mitocondrias con uni\u00f3n a cardiolipina). Explore el cat\u00e1logo completo <a href=\"https:\/\/medsbase.com\/es\/peptides\/\">peptides &amp; compounds catalog<\/a>, o consulte el <a href=\"https:\/\/medsbase.com\/es\/best-longevity-peptides\/\">longevity compounds<\/a> centro de recursos. <\/p>\n<h2>Concentraciones y potencias disponibles<\/h2>\n<p>MedsBase stocks Glutathione in three lyophilized vial sizes calibrated to typical protocol dose ranges. Each strength is available in 10-vial, 20-vial, or 30-vial pack formats:<\/p>\n<table style=\"width: 100%; border-collapse: collapse; margin: 16px 0;\">\n<thead>\n<tr style=\"background: #2c7cb0; color: #fff;\">\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Potencia del vial<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Caso de uso t\u00edpico<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Tama\u00f1os de paquete<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>600 mg<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Standard strength \u2014 entry-level protocols, in-vitro antioxidant-defence panels, dose-titration work, single-cohort murine titration; convenient for reconstitution at 100\u2013200 mg\/mL working stocks<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">10, 20 o 30 viales<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>900 mg<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Mid-strength \u2014 extended in-vivo rodent dosing protocols, IV-protocols, multi-cohort sample sizes, hepatology \/ oxidative-stress model studies<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">10, 20 o 30 viales<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>1500 mg<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">High-strength vial \u2014 clinical-translational dose-range protocols (Italian Tationil IV dosing is 600\u20132400 mg\/d for hepatology studies), large-cohort metabolic studies, multi-arm comparator work; lowest per-mg cost<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">10, 20 o 30 viales<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>All three strengths are the same chemical entity (lyophilized L-glutathione reduced form, \u226599% HPLC purity, USP-grade titration-confirmed reduced-form content). The 1500 mg vial provides the lowest per-mg cost for clinical-translational protocols. Users should determine specific dose ranges from peer-reviewed literature appropriate to the protocol. <\/p>\n<h2>Comparativa \u2014 Glutati\u00f3n vs NAD\u207a<\/h2>\n<p>El glutati\u00f3n y <a href=\"https:\/\/medsbase.com\/es\/nad\/\">NAD\u207a<\/a> son los dos compuestos peque\u00f1os de redox celular\/coenzimas m\u00e1s estudiados en este cat\u00e1logo, y se sit\u00faan en ramas conectadas pero mecanicamente distintas de la biolog\u00eda redox celular. El GSH es la principal <em>defensa antioxidante celular<\/em> mol\u00e9cula peque\u00f1a \u2014 presente en concentraciones milimolares y que reduce los per\u00f3xidos mediante el mecanismo de sustrato de la GPx. El NAD\u207a es el principal <em>transporte de electrones celular<\/em> coenzyme \u2014 reducible to NADH for electron transport in glycolysis \/ TCA cycle \/ \u03b2-oxidation, and substrate for sirtuins and PARPs. The two systems are interconnected: NADPH (made from NAD via the pentose phosphate pathway) is the reducing equivalent that regenerates GSH from GSSG via glutathione reductase. Studies that probes cellular redox biology often manipulates both pools and compares the consequences. <\/p>\n<table style=\"width: 100%; border-collapse: collapse; margin: 16px 0;\">\n<thead>\n<tr style=\"background: #2c7cb0; color: #fff;\">\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Criterio<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Glutati\u00f3n (GSH)<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">NAD\u207a<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Clase qu\u00edmica<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Trip\u00e9ptido \u03b3-glutamil (\u03b3-Glu-Cys-Gly)<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Coenzima dinucle\u00f3tido (adenina + nicotinamida + difosfato)<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Peso molecular<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">307.32 g\/mol<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">663.43 g\/mol<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Funci\u00f3n celular<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Defensa antioxidante \u2014 sustrato de la GPx (reducci\u00f3n de per\u00f3xidos), co-sustrato de la GST (conjugaci\u00f3n de xenobi\u00f3ticos), amortiguador del estado redox<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Coenzima de transporte de electrones \u2014 sustrato para la \u03b2-oxidaci\u00f3n, gluc\u00f3lisis, TCA; sustrato para sirtuinas y PARPs<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Concentraci\u00f3n celular<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">1\u201310 mM (milimolar \u2014 el tiol no proteico m\u00e1s abundante)<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">~0,3\u20131 mM (pool de NAD, micromolar a \u00b5M alto)<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Best-studied studies focus<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Defensa antioxidante, ferroptosis, detoxificaci\u00f3n de fase II, se\u00f1alizaci\u00f3n redox, hepatolog\u00eda, da\u00f1o inducido por paracetamol<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Biolog\u00eda de las sirtuinas, longevidad, envejecimiento celular, regulaci\u00f3n redox del eje NAD<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Estabilidad plasm\u00e1tica<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Corta \u2014 semivida de ~10\u201315 min (degradaci\u00f3n extracelular mediada por \u03b3-GT)<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Muy corta \u2014 minutos (se oxida y degrada r\u00e1pidamente en soluci\u00f3n)<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Conexi\u00f3n<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">El NADPH (derivado del NAD) regenera el GSH a partir del GSSG mediante la glutati\u00f3n reductasa<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">La conexi\u00f3n del NADPH vincula el pool de NAD con la capacidad de reducci\u00f3n del sistema GSH<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Uso cl\u00ednico<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Inyectable aprobado en Italia\/Jap\u00f3n\/Corea (Tationil y similares; hepatolog\u00eda, estr\u00e9s oxidativo)<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Not approved as a clinical therapeutic; studies-only compound<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>For studies focused on cellular antioxidant defence, ferroptosis, Phase II detoxification, or redox signalling, Glutathione is the canonical reference compound. For studies focused on sirtuin biology, longevity-axis biochemistry, or NAD-dependent redox regulation, <a href=\"https:\/\/medsbase.com\/es\/nad\/\">NAD\u207a<\/a> is the more targeted tool. The two compounds are commonly co-administered in studies that probes the integrated cellular-redox-system response to oxidative stress, ageing, or mitochondrial dysfunction. <\/p>\n<div style=\"background: #f4f8fb; border-left: 4px solid #2c7cb0; padding: 14px 18px; margin: 18px 0;\"><strong class=\"mb-bac-water-callout\">\ud83d\udca7 \u00bfNecesitas agua BAC?<\/strong> La reconstituci\u00f3n de cualquier vial liofilizado requiere agua bacteriost\u00e1tica est\u00e9ril. Combina este producto con nuestro <a href=\"\/es\/bac-water\/\"><strong>Agua BAC (Agua Bacteriost\u00e1tica)<\/strong><\/a> \u2014 vial multidosis de 30 mL, conservado con alcohol benc\u00edlico 0.9%, grado USP.<\/div>\n<h2>Almacenamiento y reconstituci\u00f3n<\/h2>\n<p><strong>Antes de la reconstituci\u00f3n:<\/strong> almacene los viales liofilizados refrigerados a 2\u20138 \u00b0C en su envase original sellado. Para almacenamiento a largo plazo, congele los viales sin abrir a \u221220 \u00b0C (estable \u226536 meses a \u221220 \u00b0C; \u226518 meses a 2\u20138 \u00b0C). El GSH liofilizado es <strong>altamente higrosc\u00f3pico<\/strong> \u2014 vuelva a sellar los viales inmediatamente despu\u00e9s de cada extracci\u00f3n para evitar la absorci\u00f3n de humedad (lo que acelera la oxidaci\u00f3n de GSH \u2192 GSSG). Proteja de la luz. <strong>Procedimiento de reconstituci\u00f3n:<\/strong> inyecte agua est\u00e9ril, agua bacteriost\u00e1tica o PBS (pH 7,2) por la pared lateral del vial (no directamente sobre el polvo liofilizado). Para un vial de 600 mg, 6,0 mL de diluyente producen una soluci\u00f3n de trabajo de 100 mg\/mL; 3,0 mL producen 200 mg\/mL. Para un vial de 900 mg, 9,0 mL producen 100 mg\/mL; 4,5 mL producen 200 mg\/mL. Para un vial de 1500 mg, 7,5 mL producen una soluci\u00f3n de 200 mg\/mL; 15 mL producen 100 mg\/mL. El GSH se disuelve r\u00e1pidamente con un suave giro a temperatura ambiente. <strong>Cr\u00edtico para el GSH reconstituido:<\/strong> el grupo tiol (-SH) es <strong>sensible a la oxidaci\u00f3n por aire<\/strong> \u2014 las soluciones reconstituidas se oxidan progresivamente a la forma GSSG, incluso refrigeradas. Prepare soluciones de trabajo frescas a partir de viales liofilizados siempre que sea posible, o util\u00edcelas dentro de los 7 d\u00edas posteriores a la reconstituci\u00f3n refrigeradas. Para el almacenamiento a largo plazo del material reconstituido, agregue quelantes (1 mM EDTA) para ralentizar la oxidaci\u00f3n catalizada por metales, almacene bajo atm\u00f3sfera inerte (purga con arg\u00f3n o nitr\u00f3geno) o utilice cosolvente DMSO (que proporciona protecci\u00f3n adicional). No congele y descongele repetidamente. Deseche si aparece un cambio de color marcado (amarillo\/marr\u00f3n) o precipitaci\u00f3n. <\/p>\n<h2>Preguntas frecuentes<\/h2>\n<h3>\u00bfCu\u00e1l es la diferencia entre el glutati\u00f3n reducido (GSH) y el oxidado (GSSG)?<\/h3>\n<p>GSH is the reduced form with a free thiol (-SH) group on its cysteine residue \u2014 the biologically active form that serves as the cellular antioxidant. GSSG is the oxidised dimer form where two GSH molecules are linked through their cysteine sulfurs by a disulfide bridge \u2014 the spent form that needs to be re-reduced to 2 GSH by glutathione reductase. The cellular GSH:GSSG ratio (typically ~100:1 in healthy cells, dropping to 10:1 or lower under oxidative stress) is the canonical biomarker of cellular redox status. We supply the reduced GSH form; users requiring GSSG specifically should consult dedicated suppliers. <\/p>\n<h3>\u00bfPor qu\u00e9 el GSH tiene un enlace pept\u00eddico \u03b3 en lugar de un enlace \u03b1 normal?<\/h3>\n<p>El enlace pept\u00eddico no est\u00e1ndar \u03b3 entre el \u03b3-COOH del glutamato y el \u03b1-NH de la ciste\u00edna<sub>2<\/sub> es lo que confiere al glutati\u00f3n su resistencia a las peptidasas celulares. Las peptidasas celulares est\u00e1ndar (aminopeptidasas, carboxipeptidasas) solo reconocen enlaces pept\u00eddicos \u03b1 y no pueden escindir el enlace \u03b3. Solo la \u03b3-glutamiltransferasa (\u03b3-GT, GGT) reconoce y escinde el enlace \u03b3 \u2014 y la \u03b3-GT es la enzima limitante de la degradaci\u00f3n del GSH, expresada principalmente en la superficie apical de c\u00e9lulas epiteliales (ri\u00f1\u00f3n, tracto biliar, etc.). Por tanto, este enlace no est\u00e1ndar es esencial para la acumulaci\u00f3n intracelular estable del glutati\u00f3n en concentraciones milimolares. <\/p>\n<h3>\u00bfPor qu\u00e9 la biodisponibilidad oral del GSH es baja?<\/h3>\n<p>Intact GSH is poorly absorbed across the intestinal epithelium because: (1) the \u03b3-peptide bond prevents recognition by the standard PEPT1 \/ PEPT2 di-\/tri-peptide transporters that absorb other tripeptides; (2) \u03b3-GT activity at the brush border degrades much of the orally-administered GSH to its constituent amino acids before absorption; (3) the cysteine that is liberated is then largely consumed by enterocyte first-pass GSH re-synthesis. The net oral bioavailability of intact GSH is therefore very low, which is why injectable preparations or N-acetylcysteine (NAC, a cysteine prodrug) are preferred for systemic GSH-boosting studies interventions. <\/p>\n<h3>What published dose ranges have been used in studies?<\/h3>\n<p>Injectable IV GSH protocol dosing typically uses 600\u20131200 mg per dose, daily or 2\u20133\u00d7\/week, for 4\u201312 weeks in human-subject studies (mirroring the Italian Tationil approved-product dose range of 600\u20132400 mg\/d). Rodent in-vivo work uses 50\u2013150 mg\/kg IV \/ IP, mirroring the dose range that produces reliable systemic GSH elevation despite the short plasma half-life. In-vitro cell-culture protocols typically use 0.5\u201310 mM in growth medium (cells take up cysteine from GSH and re-synthesise intracellular GSH). Users should consult primary literature appropriate to the specific application. <\/p>\n<h3>\u00bfPor qu\u00e9 la vida media plasm\u00e1tica del GSH es tan corta?<\/h3>\n<p>Plasma \u03b3-GT activity rapidly cleaves the \u03b3-peptide bond of circulating GSH to cysteinylglycine, which is then further cleaved by dipeptidases to cysteine + glycine. The combined \u03b3-GT + dipeptidase cascade gives intact circulating GSH a plasma half-life of only ~10\u201315 minutes. This is why repeated daily dosing is used in clinical-protocols rather than single high-dose bolus regimens, and why N-acetylcysteine (NAC) \u2014 which is taken up intact and used for intracellular GSH synthesis \u2014 is sometimes preferred as a longer-acting cysteine-source alternative for cellular GSH boosting studies. <\/p>\n<h3>Can GSH be combined with B12, NAC, or other redox \/ cofactor compounds in protocols?<\/h3>\n<p>Yes \u2014 GSH is mechanistically connected to many other cellular-redox and cofactor compounds. Common protocol combinations include: GSH + NAC (parallel cysteine-source strategies \u2014 GSH as the intact tripeptide, NAC as the cysteine prodrug \u2014 to compare extracellular vs intracellular GSH-supplementation routes); GSH + <a href=\"https:\/\/medsbase.com\/es\/b12-cyanocobalamin\/\">B12<\/a> (oxidative-stress-related neurology and methylation-cycle studies); GSH + <a href=\"https:\/\/medsbase.com\/es\/nad\/\">NAD\u207a<\/a> (disecci\u00f3n integrada del pool redox); GSH + <a href=\"https:\/\/medsbase.com\/es\/ss-31-elamipretide\/\">SS-31<\/a> (mitochondrial-targeted redox studies). Reconstitute each separately just before use and add separately rather than co-storing reconstituted solutions. <\/p>\n<h3>How does this pharmaceutical-grade GSH compare with clinical preparations like Tationil?<\/h3>\n<p>Tationil (and similar branded clinical preparations available in Italy \/ Japan \/ Korea \/ Philippines) is reduced-form L-glutathione approved as a clinical injectable for hepatology and oxidative-stress indications. The pharmaceutical-grade GSH supplied here is the same reduced-form L-glutathione at \u226599% HPLC purity, supplied without a clinical-use label and intended for clinical studies only. Users seeking clinical-use GSH should obtain it through a clinical supply chain; users seeking pharmaceutical-grade material for in-vitro and in-vivo clinical protocols can use the material supplied here. <\/p>\n<h3>\u00bfEst\u00e1 el GSH en la Lista de Prohibidos de la AMA?<\/h3>\n<p>No. El glutati\u00f3n no est\u00e1 en la Lista de Prohibidos de la AMA. Es un trip\u00e9ptido antioxidante celular de origen natural presente en concentraciones milimolares en todas las c\u00e9lulas nucleadas, por lo tanto, no est\u00e1 sujeto a restricciones regulatorias de rendimiento deportivo. <!-- medsbase-related-alts-v1 --><\/p>\n<h2>Other Small-Molecule Companion Compounds<\/h2>\n<ul>\n<li><a href=\"\/es\/b12-cyanocobalamin\/\"><strong>B12 (Cianocobalamina)<\/strong><\/a> \u2014 Cobalamin coenzyme \u2014 methylation-cycle companion<\/li>\n<li><a href=\"\/es\/l-carnitine\/\"><strong>L-Carnitina<\/strong><\/a> \u2014 Mitochondrial fatty-acid shuttle \u2014 closest small-molecule companion analogue<\/li>\n<li><a href=\"\/es\/nad\/\"><strong>NAD\u207a<\/strong><\/a> \u2014 Oxidised dinucleotide coenzyme \u2014 direct NAD-pool \/ electron-transport studies<\/li>\n<li><a href=\"\/es\/5-amino-1mq\/\"><strong>5-Amino-1MQ<\/strong><\/a> \u2014 Inhibidor de NNMT \u2014 ahorro de precursores del eje NAD, amortiguaci\u00f3n del pool de metilaci\u00f3n<\/li>\n<li><a href=\"\/es\/ss-31-elamipretide\/\"><strong>SS-31 (Elamipretide)<\/strong><\/a> \u2014 P\u00e9ptido antioxidante dirigido a mitocondrias con uni\u00f3n a cardiolipina<\/li>\n<li><a href=\"\/es\/bac-water\/\"><strong>Agua BAC (Agua Bacteriost\u00e1tica)<\/strong><\/a> \u2014 Necesaria para reconstituir cualquier vial liofilizado \u2014 diluyente est\u00e9ril conservado con alcohol benc\u00edlico al 0.9%<\/li>\n<\/ul>","protected":false},"excerpt":{"rendered":"<p>\u2705 \u03b3-Glutamil trip\u00e9ptido (\u03b3-Glu-Cys-Gly) \u2014 tiol celular primario no proteico<br \/>\n\u2705 Sustrato de GPx (reducci\u00f3n de per\u00f3xido) + co-sustrato de GST (conjugaci\u00f3n de xenobi\u00f3ticos) + amortiguador del estado redox<br \/>\n\u2705 Enlace pept\u00eddico \u03b3 \u00fanico \u2014 resistente a peptidasas; solo la \u03b3-GT lo escinde<br \/>\n\u2705 Canonical reference compound for cellular antioxidant defence studies<br \/>\n\u2705 Forma reducida liofilizada grado USP; CAS 70-18-8, PM 307.32<\/p>\n<p><strong>L-Glutati\u00f3n (Reducido \/ GSH)<\/strong> contains the \u03b3-glutamyl-cysteinyl-glycine tripeptide compound.<\/p>","protected":false},"featured_media":71535,"comment_status":"open","ping_status":"closed","template":"","meta":[],"product_brand":[],"product_cat":[5426],"product_tag":[6517,6516,5737,4442,6519,6494,6518],"class_list":["post-71470","product","type-product","status-publish","has-post-thumbnail","product_cat-peptides","product_tag-antioxidant-peptide","product_tag-glutathione-reduced","product_tag-gsh","product_tag-l-glutathione","product_tag-redox-research","product_tag-research-peptide","product_tag-tripeptide-research-compound","first","instock","shipping-taxable","purchasable","product-type-variable","has-default-attributes"],"acf":[],"_links":{"self":[{"href":"https:\/\/medsbase.com\/es\/wp-json\/wp\/v2\/product\/71470","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medsbase.com\/es\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/medsbase.com\/es\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/medsbase.com\/es\/wp-json\/wp\/v2\/comments?post=71470"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medsbase.com\/es\/wp-json\/wp\/v2\/media\/71535"}],"wp:attachment":[{"href":"https:\/\/medsbase.com\/es\/wp-json\/wp\/v2\/media?parent=71470"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/medsbase.com\/es\/wp-json\/wp\/v2\/product_brand?post=71470"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/medsbase.com\/es\/wp-json\/wp\/v2\/product_cat?post=71470"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/medsbase.com\/es\/wp-json\/wp\/v2\/product_tag?post=71470"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}